The Serum Analysis of Dampness Syndrome in Patients with Coronary Heart Disease and Chronic Renal Failure Based on the Theory of “Same Syndromes in Different Diseases”

<table class="table-group" id="tab4"><tr><td><table class="table"><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr class="thead"><td class="align_left"><svg height="11.439pt" id="M53" style="vertical-align:-2.15067pt" version="1.1" viewbox="-0.0498162 -9.28833 27.3585 11.439" width="27.3585pt" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><g transform="matrix(.013,0,0,-0.013,0,0)"><path d="M962 650H795L470 145L347 650H176L170 622C268 613 275 606 244 503L190 322C150 188 132 126 118 91C102 50 80 33 18 28L12 0H245L251 28C175 35 170 48 174 93C177 128 191 180 220 284L292 542H294C331 392 383 150 409 4H432L774 555H776L714 137C700 40 694 34 612 28L606 0H868L874 28C793 34 784 37 797 137L849 533C859 612 863 616 956 622L962 650Z" id="g113-78"></path><glyph.data ascent="3473" descent="-2876" horiz-adv-x="985" vert-adv-y="985" xpluscharwidth="12.805"></glyph.data></g><g transform="matrix(.013,0,0,-0.013,12.807,0)"><path d="M368 703H309L44 -163H104L368 703Z" id="g113-48"></path><glyph.data ascent="3473" descent="-2876" horiz-adv-x="412" vert-adv-y="412" xpluscharwidth="18.163"></glyph.data></g><g transform="matrix(.013,0,0,-0.013,18.168,0)"><path d="M669 636L663 650H260C230 650 221 652 208 675H186C177 621 162 548 144 481L173 479C195 534 211 560 226 578C248 604 266 615 373 615H544C460 511 114 112 23 16L31 0H561C577 34 611 135 622 170L594 182C566 125 544 88 515 65C481 38 416 35 319 35C249 35 197 37 152 41C270 184 542 501 669 636Z" id="g113-91"></path><glyph.data ascent="3473" descent="-2876" horiz-adv-x="692" vert-adv-y="692" xpluscharwidth="27.164"></glyph.data></g></svg></td><td class="align_center">Formula</td><td class="align_center">Metabolites</td></tr><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr><td class="align_left">130.0630</td><td class="align_center">C6H10O3</td><td class="align_center">2-oxo-3-Methylvaleric acid</td></tr><tr><td class="align_left">224.0797</td><td class="align_center">C10H12N2O4</td><td class="align_center">3-Hydroxy-DL-kynurenine acid</td></tr><tr><td class="align_left">143.0582</td><td class="align_center">C6H9NO3</td><td class="align_center">Vinylacetylglycine</td></tr><tr><td class="align_left">318.2559</td><td class="align_center">C21H34O2</td><td class="align_center">Pregnenolone</td></tr><tr><td class="align_left">226.0590</td><td class="align_center">C9H10N2O5</td><td class="align_center">Nitrotyrosine</td></tr><tr><td class="align_left">281.1124</td><td class="align_center">C11H15N5O4</td><td class="align_center">1-Methyladenosine</td></tr><tr><td class="align_left">160.0372</td><td class="align_center">C6H8O5</td><td class="align_center">Oxoadipic acid</td></tr><tr><td class="align_left">106.0773</td><td class="align_center">C3H6O4</td><td class="align_center">Glyceric acid</td></tr><tr><td class="align_left">192.0270</td><td class="align_center">C6H8O7</td><td class="align_center">Citric acid</td></tr><tr><td class="align_left">89.9045</td><td class="align_center">C4H8O2</td><td class="align_center">Isobutyric acid</td></tr><tr class="table-tr"><td colspan="3"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Differential metabolites existing in the serums of patients with CHD showing dampness syndrome compared to the serums of healthy subjects.

BioMed Research International

tab4

Table 4

Table 4: The Serum Analysis of Dampness Syndrome in Patients with Coronary Heart Disease and Chronic Renal Failure Based on the Theory of “Same Syndromes in Different Diseases” 

Table 4 | The Serum Analysis of Dampness Syndrome in Patients with Coronary Heart Disease and Chronic Renal Failure Based on the Theory of “Same Syndromes in Different Diseases” 